Nanobiotix S.A. ADR (NBTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2020 | 12-2019 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 29,278 | 39,305 |
| Receivables | 56 | 12 |
| Other current assets | 9,497 | 12,345 |
| TOTAL | $38,831 | $51,662 |
| Non-Current Assets | ||
| PPE Net | N/A | 14,781 |
| Investments And Advances | 512 | 592 |
| Other Non-Current Assets | 80 | 183 |
| TOTAL | $592 | $15,556 |
| Total Assets | $49,291 | $62,950 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 9,765 | 8,702 |
| Other current liabilities | 9,108 | 7,366 |
| TOTAL | $18,873 | $16,069 |
| Non-Current Liabilities | ||
| Other Non-Current Liabilities | 54,856 | 49,018 |
| TOTAL | $54,856 | $49,018 |
| Total Liabilities | $73,729 | $65,087 |
| Shareholders' Equity | ||
| Common Shares | 751 | 753 |
| Retained earnings | -22,660 | -57,025 |
| Other shareholders' equity | -169,861 | -117,381 |
| TOTAL | $-24,438 | $-2,137 |
| Total Liabilities And Equity | $49,291 | $62,950 |